Top-News
Gesundheitswesen Frankreich

DBV Technologies News

Aktie
WKN:  A1JWB7 ISIN:  FR0010417345 US-Symbol:  DBVTF
1,09 €
-0,074 €
-6,36%
17:04:56 Uhr
Handeln Depot/Watchlist
Aktienanzahl *
94,02 Mio.
Marktkapitalisierung *
109,44 Mio. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 21.06.2022

DBV Technologies News

05.06.24 - GlobeNewswire
DBV Technologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
Châtillon, France, June 5, 2024 DBV Technologies to Participate in the Goldman Sachs 45 th Annual Global Healthcare Conference DBV Technologies (Euronext: DBV – ISIN ...
04.06.24 - GlobeNewswire
Information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2024
Information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2024 (Article 223-16 of the General Regulations of the Autorité des ...
31.05.24 - GlobeNewswire
DBV Technologies Announces Plan to Implement ADS Ratio Change
Châtillon, France, May 31, 2024 DBV Technologies Announces Plan to Implement ADS Ratio Change DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock ...
30.05.24 - GlobeNewswire
DBV Technologies to Participate in Upcoming EAACI 2024 Congress
Châtillon, France, May 30, 2024 DBV Technologies to Participate in Upcoming EAACI 2024 Congress DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock ...
17.05.24 - GlobeNewswire
DBV Technologies Announces Plan to Implement ADS Ratio Change
Châtillon, France, May 17, 2024 DBV Technologies Announces Plan to Implement ADS Ratio Change DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock ...
16.05.24 - GlobeNewswire
DBV Technologies Announces Results of its 2024 Combined General Meeting
Châtillon, France, May 16, 2024 DBV Technologies Announces Results of its 2024 Combined General Meeting Shareholders approved all proposed resolutions DBV Technologies ...
09.05.24 - GlobeNewswire
DBV Technologies to Participate in Upcoming Investor Conferences
Montrouge, France, May 9, 2024
07.05.24 - GlobeNewswire
DBV Technologies Reports First Quarter 2024 Financial Results and Business Update
Montrouge, France, May 7, 2024 DBV Technologies Reports First Quarter 2024 Financial Results and Business Update VITESSE enrollment on track to screen last patient by Q3 ...
25.04.24 - GlobeNewswire
Combined General Meeting of May 16, 2024
Châtillon, France, April 25, 2024 Combined General Meeting of May 16, 2024 Procedures for Obtaining Information and Preparatory Documents for the Combined General Meeting ...
04.04.24 - GlobeNewswire
Information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2024
Information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2024 (Article 223-16 of the General Regulations of the Autorité des ...
08.03.24 - GlobeNewswire
DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Document
Montrouge, France, March 8, 2024 DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Document DBV Technologies (Euronext ...
07.03.24 - GlobeNewswire
DBV Technologies Reports Full Year 2023 Financial Results and Business Update
Montrouge, France, March 7, 2024 DBV Technologies Reports Full Year 2023 Financial Results and Business Update Advanced Viaskin™ Peanut clinical development programs in ...
04.03.24 - GlobeNewswire
DBV Technologies to Report Full Year 2023 Financial Results and Business Update on March 7, 2024
Montrouge, France, March 4, 2024 DBV Technologies to Report Full Year 2023 Financial Results and Business Update on March 7, 2024 DBV Technologies (Euronext: DBV – ISIN ...
20.02.24 - GlobeNewswire
DBV Technologies to Participate in Upcoming AAAAI 2024 Congress
Montrouge, France, February 20 2024 DBV Technologies to Participate in Upcoming AAAAI 2024 Congress DBV Technologies (Euronext: DBV – ISIN: FR0010417345 –NASDAQ ...
16.01.24 - GlobeNewswire
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
AMF Regulated Information Montrouge, France, January 16, 2024 Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF DBV Technologies (Euronext: DBV – ...
04.12.23 - GlobeNewswire
Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2023  
Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2023 (Article 223-16 of the General Regulations of the Autorité ...
09.11.23 - GlobeNewswire
DBV Technologies Announces 2-Year Results from Ongoing Phase 3 Open-Label Extension to the EPITOPE Trial (EPOPEX) of Viaskin™ Peanut in Toddlers
Montrouge, France, November 9, 2023 DBV Technologies Announces 2-Year Results from Ongoing Phase 3 Open-​Label Extension to the EPITOPE Trial (EPOPEX) of Viaskin™ ...
06.11.23 - GlobeNewswire
Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2023
Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2023
02.11.23 - GlobeNewswire
DBV Technologies to Present New Data at ACAAI 2023
Montrouge, France, November 2, 2023 DBV Technologies to Present New Data at ACAAI 2023 New data to include late-​breaking abstract detailing interim 12-month results from the ...
31.10.23 - GlobeNewswire
DBV Technologies Receives Requested Feedback from FDA on Protocol Design Elements for COMFORT Safety Studies and Reports Third Quarter 2023 Financial Results
Montrouge, France, October 31, 2023 DBV Technologies Receives Requested Feedback from FDA on Protocol Design Elements for COMFORT Safety Studies and Reports Third ...

Newssuche

Videos

06.06.24 +12,50%
Technical Trading: Erdgas nach Rücksetzer Long
Erdgas Long Typ: Turbo Open End WKN: VM6KAH Hebel: 2,11 Laufzeit: OpenEnd Einstieg: Market ... Mehr »